Executive Director
Cambridge, Cambridgeshire, Gb
Head of US Site Management and Monitoring for Phase I through III programs. I led a group of 280 people, both regionally and headquarters-based, who were responsible for site selection, contracting, start-up, eTMF and CTMS maintenance, monitoring and project leadership. Led the transition to an in-house monitoring group in 2017 and proud recipient of the Society for Clinical Research Sites Eagle Award in 2018. Additional contributions have included leading late-phase, full-service outsourcing, development and implementation of the late-phase sourcing strategy and implementation of risk-based quality management for the enterprise.